Amicus Therapeutics (FOLD) Tops Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts FOLD Hot Sheet
Price: $14.49 --0%
Financial Fact:
Restructuring charges: 11K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Restructuring charges: 11K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amicus Therapeutics (NASDAQ: FOLD) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $103.5 million versus the consensus estimate of $102.3 million.
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- RH shares jump after second quarter beat
- RH (RH) Tops Q2 EPS by $2.31
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
